|
 |
| CLINICAL IMAGE |
|
| Year : 2021 | Volume
: 14
| Issue : 1 | Page : 60-61 |
|
|
Misdirected ozurdex implant
Amber Amar Bhayana, Suneel Kumar, Shorya Vardhan Azad
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi, India
| Date of Submission | 27-Dec-2019 |
| Date of Decision | 07-Apr-2020 |
| Date of Acceptance | 26-Apr-2020 |
| Date of Web Publication | 27-Feb-2021 |
Correspondence Address:
Dr. Amber Amar Bhayana
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi - 110 029
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ojo.OJO_292_2019
 Abstract | | |
Ozurdex is one of the most commonly inserted intravitreal steroid implants in cases of posterior uveitis and recalcitrant macular edema in cases of diabetic retinopathy and vascular occlusions. Here we report accidental malpositioning of this implant in patellar fossa.
Keywords: Implant, misdirected, Ozurdex
How to cite this article:
Bhayana AA, Kumar S, Azad SV. Misdirected ozurdex implant. Oman J Ophthalmol 2021;14:60-1 |
A 6-year-old female, known case of juvenile idiopathic arthritis, was injected intravitreally with Ozurdex (Allergan, Irvine, CA, USA) for chronic panuveitis in the left eye which got accidentally placed anteriorly and got trapped in the anterior hyaloid face indenting the posterior capsule of the crystalline lens [Figure 1]. The eye was treated with lens sparing pars plana vitrectomy with oil insertion for developing retinal detachment and Ozurdex was explanted. Misdirected implants are rare accidental complications during intravitreal injections.[1],[2],[3],[4],[5] Decision must be taken immediately whether to intervene to prevent vision loss due to complications. | Figure 1: Slit lamp photograph of the left eye showing anteriorly placed dexamethasone implant with inferotemporal part trapped between posterior capsule and anterior hyaloid
Click here to view |
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | |  |
| 1. | Biswas P, Nandi K, Batra S, Ginodia A, Biswas P. Pars plana vitrectomy and re-directing a dexamethasone implant into vitreous cavity following misdirected entry into the crystalline lens. Indian J Ophthalmol 2018;66:1033-6.  [ PUBMED] [Full text] |
| 2. | Chhabra R, Kopsidas K, Mahmood S. Accidental insertion of dexamethasone implant into the crystalline lens-12 months follow-up. Eye (Lond) 2014;28:624-5. |
| 3. | Abdolrahimzadeh S, Plateroti P, Scarinci F, Plateroti AM. Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion. Acta Ophthalmol 2016;94:e810-1. |
| 4. | Baskan B, Cıcek A, Gulhan A, Gundogan M, Goktas S. Ozurdex completely located inside a crystallized lens-Results of 14 months. Am J Ophthalmol Case Rep 2016;4:38-40. |
| 5. | Chalioulias K, Muqit MM. Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant. Eye 2014;28:1523-4. |
[Figure 1]
|
